1202-24-0

Usage

Uses

Used in Pharmaceutical Applications:
(1R,4R)-methyl 4-carbamoylcyclohexanecarboxylate is used as a building block for the synthesis of various bioactive compounds. Its cyclohexane and carbamate functional groups are important in drug design, making it a promising candidate for the development of new pharmaceuticals.
Used in Organic Synthesis:
(1R,4R)-methyl 4-carbamoylcyclohexanecarboxylate is used as an intermediate in the production of other organic compounds. Its unique structure and functional groups make it a valuable component in the synthesis of a wide range of organic molecules.
Used in Agricultural Applications:
(1R,4R)-methyl 4-carbamoylcyclohexanecarboxylate has the potential to be used as a pesticide or herbicide in agriculture. Its chemical properties may offer effective solutions for controlling pests and weeds, contributing to increased crop yields and agricultural productivity.

Upstream product

• 15177-67-0 trans-4-(methoxycarbonyl)cyclohexanecarboxylic acid 
• 541-41-3 chloroformic acid ethyl ester 

Downstream Products

• 19145-95-0 methyl trans-4-cyanocyclohexane-1-carboxylate 

Relevant academic research and scientific papers

3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF

The present disclosure provides a compound of Formula (I′): or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, wherein Rx, X1, X2, and R1 are as defined herein, and methods of making and using same.

DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES

Provided herein are dihydropyrimidine derivatives which are useful in the treatment of HBV infection or HBV-induced diseases, as well as pharmaceutical or medical applications thereof.

PYRROLIDINYL SULFONE RORGAMMA MODULATORS

Described are RORγ modulators of the formula (I), or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein all substituents are defined herein. Also provided are pharmaceutical compositions comprising the same. Such compounds and compositions are useful in methods for modulating RORγ activity in a cell and methods for treating a subject suffering from a disease or disorder in which the subject would therapeutically benefit from modulation of RORγ activity, for example, autoimmune and/or inflammatory disorders.